We are excited to announce that CircNova, Inc., a groundbreaking biotechnology startup, has successfully raised $3,300,000 in its latest funding round—a major milestone that will accelerate the company’s drive to transform therapeutic development. CircNova harnesses the power of its proprietary AI NovaEngine™, a state-of-the-art platform designed to generate, analyze, and identify circular RNA with an unprecedented level of precision. This innovative approach not only streamlines the discovery process but also opens new avenues in the development of next-generation therapies that target a wide range of diseases. The newly secured capital will be primarily allocated towards scaling up research and development efforts, expanding the company’s expert team, and forging strategic partnerships with key stakeholders in the biotechnology sector. By investing in advanced technologies and robust computational methods, CircNova is well-positioned to translate complex biological insights into tangible, life-changing treatments. This funding will also support the refinement of the NovaEngine™, enabling even deeper insights into the molecular structures and functions of circular RNA, which are rapidly emerging as critical components in regulatory networks across numerous biological systems. As the biotechnology landscape continues to evolve, CircNova’s innovative platform offers a promising new paradigm in gene and cellular therapy development. With a commitment to scientific excellence, precision medicine, and sustainable growth, the company is poised to make significant contributions to the future of therapeutic discovery and healthcare. This pivotal moment reinforces CircNova’s role as a leader in biotechnology innovation and marks the beginning of an exciting chapter in its journey toward revolutionizing how we approach and treat diseases at the molecular level.
CircNova, Inc Secures $3.3M to Revolutionize Circular RNA Therapeutics with AI NovaEngine™
Recently funded · $3.3MBiotechnology Research
Get the full CircNova, Inc company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
